Term
| 4 nutrition recommendation themes |
|
Definition
activity
moderation
variety
proportionality |
|
|
Term
| 4 M's of diabetes management |
|
Definition
meal planning
movement
medication
monitoring |
|
|
Term
Body Mass Index Equation
Moderation |
|
Definition
| weight(lbs) x 703 / height (in) |
|
|
Term
|
Definition
<18 underweight
18-25 healthy
25-29.9 overweight
30-39.9 obese
>40 extremely obese |
|
|
Term
At risk waist circumferences
moderation |
|
Definition
|
|
Term
_ calories = 1 lb
moderation |
|
Definition
|
|
Term
cal/lb/day
1. weight loss
2. maintenance
3. weight gain
moderation |
|
Definition
|
|
Term
moderation amount/day
1. fats
2. sodium
3. cholesterol |
|
Definition
1. <10%
2. <2300 (1 tsp)
3. <300 mg |
|
|
Term
variety amount/day
1. grains
2. vegetables
3. fruits
4. milk
5. meat & beans |
|
Definition
1. 6 oz
2. 2.5 cups
3. 2 cups
4. 3 cups
5. 5.5 oz |
|
|
Term
|
Definition
|
|
Term
1. Omega 3 ethyl ethers adjunct to diet for...
2. amount/day
variety |
|
Definition
1. reducing triglyceride level
2. 1-4 g/day |
|
|
Term
| 3 energy yielding nutrients & %/day |
|
Definition
1. carbs 45-65%
2. protein 10-35%
3. fat 20-35% |
|
|
Term
| % daily value low and high |
|
Definition
|
|
Term
| 1 serving per _ grams carbs |
|
Definition
|
|
Term
| insulin most active when? |
|
Definition
|
|
Term
1. grams of carbs per snack
2. grams of carbs per day for energy needs
3. grams of carbs per meal |
|
Definition
1. ≤ 30 grams
2. ≤ 90 grams
3. ≤ 75 grams |
|
|
Term
|
Definition
1. starchy vegetables
2. fruits
3. grains
4. dairy
5. sweets |
|
|
Term
reduce the risk of chronic disease engage in...
activity |
|
Definition
| at least 30min of moderate - intense physical activity most days of the week |
|
|
Term
Manage body weight and prevent unhealthy body weight engage in...
activity |
|
Definition
| 60min of moderate - vigorous activity most days of the week and do not exceed caloric intake |
|
|
Term
to sustain weight loss engage in...
activity |
|
Definition
| 60-90 min daily moderate - intense activity most days of week and do not exceed caloric intake |
|
|
Term
_ mile/day for "sweet spot" of optimum health
activity |
|
Definition
|
|
Term
cardiovascular activity program
1. emphasis
2. higher _, _ periods
3. days/week |
|
Definition
1. intensity
2. higher heart rate, shorter periods
3. 2-3 days per week |
|
|
Term
weight loss activity
1. increase _
2. not how _ but how _
3. Heart Rate
4. days/week |
|
Definition
1. time
2. not how fast but how far
3. 60-65% max
4. most/all days of week |
|
|
Term
|
Definition
physical activity of independent living
|
|
|
Term
|
Definition
30min/day moderate activity
1.5-3 miles/day at 3-4mph
|
|
|
Term
|
Definition
60min/day moderate
3miles/day at 3-4mph
|
|
|
Term
| moderate physical activity |
|
Definition
3.5 -7 kcal/min
60-73% max heart rate
|
|
|
Term
| vigorous physical activity |
|
Definition
>7 kcal/min
74-88% max heart rate |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| 2nd generation sulfonylurea |
|
Definition
glimeperide (amaryl)
glipizide (glucotrol), XL
glyburide (diabeta, micronase)
glyburide micronized (glynase) |
|
|
Term
|
Definition
repaglinide (prandin)
nateglinide (starlix) |
|
|
Term
|
Definition
| metformin (glucophage), XL |
|
|
Term
|
Definition
rosiglitazone (avandia)
pioglitazone (actos) |
|
|
Term
|
Definition
acarbose (precose)
miglitol (glyset) |
|
|
Term
|
Definition
sitagliptin (januvia)
saxagliptin (onglyza)
vildagliptin (galvus) |
|
|
Term
|
Definition
exenatide (byetta)
liraglutide (victoza) |
|
|
Term
|
Definition
|
|
Term
|
Definition
meglitinides
glucosidase inhibitors
amylin analogs |
|
|
Term
|
Definition
sulfonylureas
meglitinides
insulin |
|
|
Term
|
Definition
metformin
glucosidase inhibitors |
|
|
Term
|
Definition
Exenatide
pramlintide
1.5kg |
|
|
Term
|
Definition
sulfonylureas
meglitinides
Exenatide & pramlintide w/ other meds
insulin |
|
|
Term
| Do not cause hypoglycemia |
|
Definition
Thiazolidinedoines
Metformin
glucosidase inhibitors
sitagliptin |
|
|
Term
| Increase serum insulin concentration |
|
Definition
sulfonylureas
insulin
glucosidase inhibitors for PP |
|
|
Term
| No effect on insulin serum concentrations |
|
Definition
metformin
glucosidase inhibitors for FBS
sitagliptin
exenatide
pramlintide |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Ultra short acting insulin |
|
Definition
aspart (novolog)
lispro (humalog)
glulisine (apidra) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
aspart
lispro
glulisine
regular |
|
|
Term
| vials stable at room temperature for and refrigerator (if open)... |
|
Definition
28 days
42 days for levemir |
|
|
Term
| Regular/NPH syringe stable for... |
|
Definition
|
|
Term
| Aspart,lispro,glulisine/NPH syringe stable for... |
|
Definition
|
|
Term
|
Definition
hypoglycemia
weight gain
lipohypertrophy
lipoatrophy (rare)
allergic reaction |
|
|
Term
| Advantages of ultra short acting |
|
Definition
at as physiological insulin
less hypoglycemia
greater flexibility in dosing |
|
|
Term
| ultra short acting disadvantages |
|
Definition
risk of hypoglycemia in no meal w/in 15min
combine with longer acting for best control
give immediately after mixing
$ compared to regular |
|
|
Term
| Long acting insulin advantages |
|
Definition
24hour basal coverage
beneficial for nocturnal hypoglycemics |
|
|
Term
| Long acting disadvantages |
|
Definition
cannot be mixed
$ compared to NPH
malignancy? |
|
|
Term
Dose change
1. Daily NPH to long acting
2. BID NPH to long acting |
|
Definition
1. keep dose the same
2. decrease dose by 20% |
|
|
Term
Average starting daily insulin dose
1.type I
2. type II |
|
Definition
1. 0.5-0.7 U/kg/day (0.1-0.4 honeymoon)
2. 0.15-0.2 U/kg/day |
|
|
Term
|
Definition
50% basal
50% divided among meals
R-R-R-N |
|
|
Term
|
Definition
2/3 in breakfast short/NPH
1/3 in dinner short/NPH
R/N-0-R/N-0
Can also do R/N-0-R-N |
|
|
Term
|
Definition
|
|